In the media
News
Other news
TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases
Read full storyOther news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyIn the media
Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland
Read full storyOther news
Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem
Read full storyOther news
entrinsic bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients
Read full storyOther news